bioRxivImmunologyPreprint
Induction of anergy in human T lymphocytes by exposure to single amino acid mutated antigens
Abstract
Anergy is a condition of immune T cells becoming sustainably inactive. Theoretically, it occurs when a T cell recognizes its antigen but cannot be active. If we could artificially induce anergy to a specific T cell clone, this should provide a therapeutic strategy for autoimmune disease. One possible method to induce anergy is to expose a T cell to an unstably presented antigen, which makes the T cell bind to the antigen but not become active due to insufficient duration of antigen presentation. The present study attempted to realize this condition in human T lymphocytes by single amino acid mutation of the antigen. As a result, the potentiality of this method for anergy-induction in human T lymphocytes was revealed. By in silico protein structure prediction, it was suggested that optimal range of contact energy between the antigen and the major histocompatibility complex was required for successful induction. From the gene expression profile, emergence of CD4+/TSHZ2+ T cell population was suggested as one of the hallmarks of anergy-induction by this method. This was the first study to demonstrate anergy-induction by the destabilized antigen strategy in human cells.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Engineered Dendritic Cell-Directed Concurrent Activation of Multiple T cell Inhibitory Pathways Induces Robust Immune Tolerance
R. R. Gudi, S. Karumuthil-Melethil, … C. Vasu·bioRxiv·Jul 18, 2019
- Immune-induced TCR-like antibodies regulate specific T cell response
Kazuki Kishida, Keisuke Kawakami, … Hisashi Arase·Nature CommunicationsPeer-reviewed·Apr 16, 2026
- Antigen-specific T cell immunotherapy by in vivo mRNA delivery
Fang‐Yi Su, Jamison C. Siebart, … Gabriel A. Kwong·bioRxiv·Oct 29, 2024
- Depletion of extracellular asparagine impairs self-reactive T cells and ameliorates autoimmunity in a murine model of multiple sclerosis
Peter Georgiev, Sheila E. Johnson, … Arlene H. Sharpe·eLifePeer-reviewed·Jul 8, 2026
- Synergistic activity of IL-2 mutein with tolerogenic ImmTOR nanoparticles leads to massive expansion of antigen-specific Tregs and protection against autoimmune disease
T. K. Kishimoto, M. Fournier, … P. O. Ilyinskii·bioRxiv·May 15, 2023
- Nanotherapy-mediated biased antigen-presenting cell reprogramming supports T cell anergy to prevent type 1 diabetes
N. Klug, El Hadji Arona Mbaye, … Jacqueline A. Burke·bioRxiv·Oct 23, 2026